Cancer pain in hospitalized patients;Smerter hos kreftpasienter innlagt i sykehus

Tidsskrift for den Norske Laegeforening

Volumn 125, Issue 4, 2005, Pages 416-418

  Holtan, Anders ^a,b   Kongsgaard, Ulf E ^a   Ohnstad, Hege Oma ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; NARCOTIC ANALGESIC AGENT;

ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; DAILY LIFE ACTIVITY; HOSPITALIZATION; HUMAN; JOB PERFORMANCE; MAJOR CLINICAL STUDY; NEUROPATHIC PAIN; NORWAY; PAIN ASSESSMENT; PREVALENCE; SLEEP; SYMPTOMATOLOGY; VISUAL ANALOG SCALE; ADULT; AGED; FEMALE; HOSPITAL PATIENT; MALE; MIDDLE AGED; NEOPLASM; PAIN; PALLIATIVE THERAPY; QUESTIONNAIRE;

ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; NEOPLASMS; NORWAY; PAIN; PAIN MEASUREMENT; PALLIATIVE CARE; PREVALENCE; QUESTIONNAIRES;

EID: 14244254725     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Higginson IJ, Hearn J, Addingto-Hall J. Epidemiology of cancer pain. I: Syles N, Fallon MT, Patt RB, red. Clinical pain management - cancer pain. London: Arnold, 2003: 21-32.
2. Caraceni A, Portenoy RK. International Association for the Study of Pain. An international survey of cancer pain. Characteristics and syndromes. Pain 1999; 82: 263-74.
3. Melsom H, Wist E. Terminalomsorg til kreftpasienter. Tidsskr Nor Lægeforen 2001; 121: 2590-2.
4. Jacox A, Carr DB, Payne R. Management of cancer pain. Clinical practice guideline. AHCPR Publication 94-1592, 1994. Washington D.C.: Agency for Health Care Policy and Research, US Department of Health and Human Services, 1994.
5. Paice JA, Toy C, Shott S. Barriers to cancer pain relief: Fear of tolerance and addiction. J Pain Symptom Manage 1998; 16: 1-9.
6. Ohnstad HO, Rui L. Prevalens 2000. Prevalensundersøkelse om smerter og smertebehandling hos kreftpasienter. http://www.rit.no/stolav/ resources/smerte+prevalens2.doc (6.1.2005).
7. Verity. TeleForm. www.verity.com (15.6.2004).
8. Cleeland CS. Measurement and prevalence of pain in cancer. Semin Oncol Nurs 1985; 1: 87-92.
9. Klepstad P, Loge JH, Borchgrevink PC et al. The Norwegian Brief Pain Inventory Questionnaire: Translation and validation in cancer pain patients. J Pain Symptom Manage 2002; 24: 517-25.
10. Price DD, Bush FM, Long S et al. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain 1994; 56: 217-26.
11. Caraceni A, Cherny N, Fainsinger R et al. Pain measurement tools and methods in clinical research in palliative care: Recommendations of an expert working group of the European Association of Palliative Care. J Pain Symptom Manage 2002; 23: 239-55.
12. Zech DF, Grond S, Lynch J et al. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 1995; 63: 65-76.
13. Grand S, Zech D, Schug SA et al. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 1991; 6: 411-22.
14. World Health Organization. Cancer pain relief. Genève: WHO, 1996.
15. Portenoy RK. Cancer pain. Epidemiology and syndromes. Cancer 1989; 63: 2298-307.
16. Cascinu S, Giordani P, Agostinelli R et al. Pain and its treatment in hospitalized patients with metastatic cancer. Support Care Cancer 2003; 11: 587-92.
17. Vielvoye-Kerkmeer AP, Mattern C, Uitendaal MP. Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine. J Pain Symptom Manage 2000; 19: 185-92.
18. Mystakidou K, Parpa E, Tsilika E et al. Pain management of cancer patients with transdermal fentanyl: A study of 1828 step I, II and III transfers. J Pain 2004; 5: 119-32.
19. Borchgrevink PC, Klepstad P, Kongsgaard UE et al. Bruk av opioider mot sterke kreftrelaterte smerter. Tidsskr Nor Lægeforen 2004; 124: 337-8.
20. Martin LA, Hagen NA. Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies. J Pain Symptom Manage 1997; 14: 99-117.
21. Jensen TS, Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 2003; 102: 1-8.
22. Wilkie DJ, Huang HY, Reilly N et al. Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. J Pain Symptom Manage 2001; 22: 899-910.
23. Patt RB. Cancerpain. Philadelphia, PA: Lippincott, 1993.
24. Gebhard GF. Visceral pain. I Seattle, WA: IASP Press 1995: 5.
25. Kannan TR, Saxena A, Bhatnagar S et al. Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients. J Pain Symptom Manage 2002; 23: 60-5.
26. Farrar JT, Portenoy RK. Neuropathic cancer pain: the role of adjuvant analgesics. Oncology (Huntingt) 2001; 15: 1435-42, 1445.